bioMerieux S.A. buy UBS Group AG
Start price
24.08.24
/
50%
€103.80
Target price
24.08.25
-
Performance (%)
22.64%
End price
25.08.25
€127.30
Summary
This prediction ended on 25.08.25 with a price of €127.30. The prediction had a final performance of 22.64%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| bioMerieux S.A. | -2.493% | -2.493% | -6.549% |
| iShares Core DAX® | -1.933% | 2.239% | 16.921% |
| iShares Nasdaq 100 | -0.972% | 0.226% | 5.003% |
| iShares Nikkei 225® | -2.056% | 5.685% | 19.218% |
| iShares S&P 500 | -1.185% | 0.867% | 2.378% |
Comments by UBS_Group_AG for this prediction
In the thread bioMerieux S.A. diskutieren
bioMérieux S.A. (OTCMKTS: BMXMF) was upgraded by analysts at UBS Group AG to a "strong-buy" rating.
Ratings data for BMXMF provided by MarketBeat
In the thread Trading bioMerieux S.A.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten